TY - JOUR
T1 - Adipocytokines in renal transplant recipients Kristof Nagy1
AU - Nagaraju, Shankar Prasad
AU - Rhee, Connie M.
AU - Mathe, Zoltan
AU - Molnar, Miklos Z.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - In the last two decades, perceptions about the role of body fat have changed. Adipocytes modulate endocrine and immune homeostasis by synthesizing hundreds of hormones, known as adipocytokines. Many studies have been investigating the influences and effects of these adipocytokines and suggest that they are modulated by the nutritional and immunologic milieu. Kidney transplant recipients (KTRs) are a unique and relevant population in which the function of adipocytokines can be examined, given their altered nutritional and immune status and subsequent dysregulation of adipocytokine metabolism. In this review,we summarize the recent findings about four specific adipocytokines and their respective roles in KTRs.We decided to evaluate the most widely described adipocytokines, including leptin, adiponectin, visfatin and resistin. Increasing evidence suggests that these adipocytokinesmay lead to cardiovascular events and metabolic changes in the general population andmay also increase mortality and graft loss rate in KTRs. In addition, we present findings on the interrelationship between serum adipocytokine levels and nutritional and immunologic status, and mechanisms by which adipocytokines modulate morbidity and outcomes in KTRs.
AB - In the last two decades, perceptions about the role of body fat have changed. Adipocytes modulate endocrine and immune homeostasis by synthesizing hundreds of hormones, known as adipocytokines. Many studies have been investigating the influences and effects of these adipocytokines and suggest that they are modulated by the nutritional and immunologic milieu. Kidney transplant recipients (KTRs) are a unique and relevant population in which the function of adipocytokines can be examined, given their altered nutritional and immune status and subsequent dysregulation of adipocytokine metabolism. In this review,we summarize the recent findings about four specific adipocytokines and their respective roles in KTRs.We decided to evaluate the most widely described adipocytokines, including leptin, adiponectin, visfatin and resistin. Increasing evidence suggests that these adipocytokinesmay lead to cardiovascular events and metabolic changes in the general population andmay also increase mortality and graft loss rate in KTRs. In addition, we present findings on the interrelationship between serum adipocytokine levels and nutritional and immunologic status, and mechanisms by which adipocytokines modulate morbidity and outcomes in KTRs.
UR - http://www.scopus.com/inward/record.url?scp=84978998408&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978998408&partnerID=8YFLogxK
U2 - 10.1093/ckj/sfv156
DO - 10.1093/ckj/sfv156
M3 - Review article
AN - SCOPUS:84978998408
SN - 2048-8505
VL - 9
SP - 359
EP - 373
JO - CKJ: Clinical Kidney Journal
JF - CKJ: Clinical Kidney Journal
IS - 3
ER -